Gilead Sciences is in a powerful bull channel with accumulation building. Get the target for GILD. More
- ADVERTISEMENT
-
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
GILD
Recent Articles
5 Best Closed End Funds to Buy
Check out these five great closed end funds that offer investors upside in today’s low-interest-rate environment: More
Buying Gilead Sciences Under $66 Would Be a Steal
After a post-earnings pop, Gilead Sciences (GILD) could retrace to support. More
Experimental Hepatitis Drug Called ‘Historic’ and a ‘Game Changer’
A Food and Drug Administration panel voted 15-0 to approve an experimental hepatitis C drug. The drug is made by Gilead Sciences. More
Veeva Systems’ CEO on Driving High Growth AND Profits
Veeva Systems' IPO was red-hot today, surging up 86%. Here's what the company's CEO had to say about the success of VEEV. More
Cloud Computing, 3D Printing Star in Upcoming IPOs
German 3D printer-maker Voxeljet (VJET) and cloud platform operator Veeva Systems (VEEV) are among four companies slated to pull off IPOs this week. More
Don’t Pass Up the Chance to Buy This Top Biotech at a Discount
The recent pullback is offering an opportunity to get Gilead Sciences (GILD) at a bargain price. More
